University Medical Center
Welcome,         Profile    Billing    Logout  
 23 Trials 
57 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
III, Charles F Reynolds
CREST-H, NCT03121209: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics

Active, not recruiting
3
385
Canada, US
Revascularization, Intensive Medical Management (IMM) alone
Columbia University, National Institute of Neurological Disorders and Stroke (NINDS), Mayo Clinic, University of Alabama at Birmingham, University of Maryland, University of California, Los Angeles
Internal Carotid Artery Stenosis, Cognitive Impairment
01/27
07/27
OVATION 2, NCT03393884: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer

Checkmark Presentation of OVATION 2 data in advanced ovarian cancer
Mar 2021 - Mar 2021: Presentation of OVATION 2 data in advanced ovarian cancer
Active, not recruiting
1/2
130
Canada, US
IMNN-001, Carboplatin, Paclitaxel
Imunon
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
07/24
11/25
NCT03500757: Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation

Enrolling by invitation
N/A
15
US
HoloLens, headset
Case Comprehensive Cancer Center
Percutaneous Tumor Ablation
02/25
02/25
CREST-2, NCT02089217: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Active, not recruiting
N/A
2486
Europe, Canada, US, RoW
Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS
Thomas G. Brott, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Carotid Stenosis
02/26
02/26
Marrouche, Nassir F
EDORA, NCT04704050: Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

Terminated
4
22
US
dronedarone 400 mg Oral Tablet, Multaq®, Placebo
Tulane University School of Medicine, University of Washington, Marrek, INC, Sanofi, Preventice, Mckesson
Atrial Fibrillation, Atrial Fibrillation Recurrent
12/22
12/22
FROZEN-AF, NCT04133168: Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Completed
N/A
458
Europe, Canada, US, RoW
Boston Scientific Cardiac Cryoablation System
Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
11/22
08/23
NCT04843371: PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Recruiting
N/A
500
US
Photoplethysmography
Tulane University
Valvular Heart Disease, Pericardial Disease, Cardiomyopathies
04/26
04/26
WEAICOR, NCT04605965: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19

Active, not recruiting
N/A
200
US
Tulane University, Biostrap
Covid19, Cardiovascular Complication, Behavioral Changes
09/25
09/25
COAG-AF, NCT04947657: The CoAGulation Biomarkers and Atrial Fibrillation () Pilot Study

Recruiting
N/A
20
US
Tulane University
Atrial Fibrillation
12/26
12/26
NCT04769310: Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study

Recruiting
N/A
120
US
Cardiac and Brain MRI
Tulane University
Atrial Fibrillation, Stroke, Stroke, Cardiovascular, Vascular Cognitive Impairment, Strokes Thrombotic, Stroke, Ischemic
01/26
01/26
NCT05014802: Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Recruiting
N/A
50
US
Tulane University
Atrial Fibrillation, Atrial Arrhythmia, Atrial Flutter, Atrial Tachycardia
08/26
08/26
HEARTBEAT, NCT06753045: Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

Recruiting
N/A
10000
US
Smartwatch
Tulane University, Samsung Electronics
Heart Diseases
10/27
10/27
NCT04814420: Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

Recruiting
N/A
60
US
Delayed enhancement magnetic resonance imaging (DE-MRI)
Tulane University
Atrial Fibrillation, Obstructive Sleep Apnea
12/25
12/25
TiPP, NCT04703166: Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Not yet recruiting
N/A
300
US
Samsung Galaxy Watch Active2
Tulane University School of Medicine, Samsung, Preventice
Atrial Fibrillation
12/27
12/27
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, not recruiting
N/A
525
US
Investigational LUX-Dx ICM Implant
Boston Scientific Corporation
Heart Failure
05/26
06/26
Fuloria, Jyotsna
AGO-Gard, NCT05266898: Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

Recruiting
4
150
US
Human papillomavirus 9-valent vaccine, recombinant, Gardasil-9
Louisiana State University Health Sciences Center in New Orleans, Merck Sharp & Dohme LLC
Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection, Serology, Cervical Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Oral Cavity Infection
06/24
03/25
GBT021601-021, NCT05431088: A Phase 2/3 Study in Adult and Pediatric Participants With SCD

Active, not recruiting
2/3
429
Europe, US, RoW
Osivelotor, PF-07940367 or GBT021601
Pfizer, Pfizer
Sickle Cell Disease
10/28
10/28
ACCRU-GI-2008, NCT05168163: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Recruiting
2
122
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Cabozantinib, Lenvatinib, E7080, ER-203492-00, Multi-Kinase Inhibitor E7080
Academic and Community Cancer Research United, National Cancer Institute (NCI), Genentech, Inc.
Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
12/24
12/26
ACCRU-BR-1701, NCT04197687: TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Recruiting
2
480
US
Multi-epitope HER2 Peptide Vaccine TPIV100, HER2/Neu Peptide Vaccine TPIV100, Peptide Vaccine TPIV100, TPIV 100, TPIV-100, TPIV100, Pertuzumab, 2C4, 2C4 Antibody, HS627, MoAb 2C4, Monoclonal Antibody 2C4, Omnitarg, Perjeta, Pertuzumab Biosimilar HS627, rhuMAb2C4, RO4368451, Placebo Administration, Sargramostim, 23-L-Leucinecolony-Stimulating Factor 2, DRG-0012, Leukine, Prokine, rhu GM-CFS, Sagramostim, Sargramostatin, Trastuzumab, ABP 980, ALT02, Anti-c-ERB-2, Anti-c-erbB2 Monoclonal Antibody, Anti-ERB-2, Anti-erbB-2, Anti-erbB2 Monoclonal Antibody, Anti-HER2/c-erbB2 Monoclonal Antibody, Anti-p185-HER2, c-erb-2 Monoclonal Antibody, HER2 Monoclonal Antibody, Herceptin, Herceptin Biosimilar PF-05280014, Herceptin Trastuzumab Biosimilar PF-05280014, Herzuma, Kanjinti, MoAb HER2, Monoclonal Antibody c-erb-2, Monoclonal Antibody HER2, Ogivri, Ontruzant, PF-05280014, rhuMAb HER2, RO0452317, SB3, Trastuzumab Biosimilar ABP 980, Trastuzumab Biosimilar ALT02, trastuzumab biosimilar EG12014, Trastuzumab Biosimilar HLX02, Trastuzumab Biosimilar PF-05280014, Trastuzumab Biosimilar SB3, Trastuzumab Biosimilar SIBP-01, Trastuzumab-anns, Trastuzumab-dkst, Trastuzumab-dttb, Trastuzumab-pkrb, Trastuzumab-qyyp, Trazimera, Trastuzumab Emtansine, Ado Trastuzumab Emtansine, ADO-Trastuzumab Emtansine, Kadcyla, PRO132365, RO5304020, T-DM1, Trastuzumab-DM1, Trastuzumab-MCC-DM1, Trastuzumab-MCC-DM1 Antibody-Drug Conjugate, Trastuzumab-MCC-DM1 Immunoconjugate
Academic and Community Cancer Research United, National Cancer Institute (NCI)
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7
01/25
01/25
NCT05249101: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

Recruiting
1/2
70
US
Ivaltinostat, Capecitabine, Xeloda
CG Pharmaceuticals, Inc
Metastatic Pancreatic Adenocarcinoma
02/26
06/26
ASIST, NCT05322590: BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Active, not recruiting
1/2
195
US
BXQ-350, SapC-DOPS, Placebo
Bexion Pharmaceuticals, Inc., ICON plc, CTI Clinical Trial and Consulting Services
Metastatic Colorectal Carcinoma, Neuropathy
04/26
04/29
NCT06451497: Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Recruiting
1
33
US
ZM008, Antibody
Zumutor Biologics Inc.
Non Small Cell Lung Cancer, Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Pancreas Adenocarcinoma, Biliary Tract Cancer, Prostate Cancer, Urothelial Carcinoma, Colorectal Cancer, Triple Negative Breast Cancer, High Grade Ovarian Serous Adenocarcinoma, Diffuse Large B Cell Lymphoma
12/26
04/27
GUARDD-US, NCT04191824: Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

Completed
N/A
6754
US
APOL1 status
Duke University, National Human Genome Research Institute (NHGRI), Icahn School of Medicine at Mount Sinai, University of Florida, Indiana University School of Medicine, Vanderbilt University Medical Center
Renal Disease, Hypertension
04/24
05/24
NCT05172024: Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

Active, not recruiting
N/A
15178
US
NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI)
SARS-CoV2 Infection
04/25
05/25
King, Brett
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Checkmark Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata
Apr 2021 - Apr 2021: Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata
Checkmark From BRAVE-AA1 trial for alopecia areata
Oct 2020 - Oct 2020: From BRAVE-AA1 trial for alopecia areata
Active, not recruiting
2/3
824
Japan, US, RoW
Baricitinib, LY3009104, Placebo
Eli Lilly and Company, Incyte Corporation
Alopecia Areata
02/21
01/25
REVEAL, NCT04338581: Evaluation of AMG 714 for Vitiligo

Active, not recruiting
2
57
US
AMG 714, Placebo, nbUVB phototherapy, narrow band ultraviolet B phototherapy
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), PPD DEVELOPMENT, LP, Rho Federal Systems Division, Inc., Amgen
Vitiligo
10/24
04/25
NCT05866562: Dupilumab in the Treatment of Pediatric Alopecia Areata

Recruiting
2
76
US
Dupilumab, Dupixent, Placebo
Icahn School of Medicine at Mount Sinai
Alopecia Areata
05/28
05/29
Smart, Frank
NCT05592275: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Active, not recruiting
2
456
Europe, Canada, Japan, US, RoW
LY3540378, Placebo
Eli Lilly and Company
Heart Failure, Heart Failure With Preserved Ejection Fraction
01/25
01/25
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Recruiting
N/A
500
Europe, US, RoW
Hearo App
Cordio Medical
Heart Failure
01/25
03/25
Wibbenmeyer, Lucy
VICToRY, NCT04138394: VItamin C in Thermal injuRY: The Trial

Recruiting
3
666
Europe, Canada, US, RoW
Ascorbic Acid, vitamin C, placebo, saline, D5W
Clinical Evaluation Research Unit at Kingston General Hospital, Dr. Christian Stoppe, MD, Co-Principal Investigator, Wurzburg University, Wurzburg, Germany
Shock, Thermal Burn
12/26
06/27
NCT04040660: Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

Approved for marketing
N/A
US
NexoBrid
MediWound Ltd
Thermal Burn
 
 
NCT06131203: Burn Validation Study

Recruiting
N/A
240
US
DeepView SnapShot Portable (DV-SSP)
SpectralMD
Burns, Wound Heal, Wounds and Injuries
03/25
04/25
ABRUPT2, NCT04356859: The Acute Burn ResUscitation Multicenter Prospective Trial

Recruiting
N/A
400
Canada, US
Albumin Human, albumin
American Burn Association, United States Department of Defense
Burn Injury
08/25
09/25
Phelan, Herb
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
Chang, Jimmin
NCT05821101: Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

Recruiting
N/A
30
US
Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50.
Debbie S. Kuo, MD, Alcon Research
Aphakia, Postcataract
12/25
06/26
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
Smith, Alison
NCT05120726: A Novel Therapeutic Treatment of Pyoderma Gangrenosum

Recruiting
4
20
US
Dehydrated human amnion/chorion membrane, EpiFix, dHACM
Louisiana State University Health Sciences Center in New Orleans
Pyoderma Gangrenosum
12/24
05/26
MASTR, NCT05243966: Myriad™ Augmented Soft Tissue Reconstruction Registry

Recruiting
N/A
800
US
Myriad Matrix™ and Myriad Morcells™
Aroa Biosurgery Limited
Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury
01/28
01/29
Lennard, Shana
DHA, NCT06024512: DeepView Snapshot Handheld (DV-H) Comparison Study

Completed
N/A
18
US
Burn
SpectralMD
Burns
01/24
01/24
NCT06131203: Burn Validation Study

Recruiting
N/A
240
US
DeepView SnapShot Portable (DV-SSP)
SpectralMD
Burns, Wound Heal, Wounds and Injuries
03/25
04/25
NCT05877638: SWC for Treatment of Superficial Partial-Thickness Burns

Terminated
N/A
2
US
SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel, SILVADENE Cream 1% (silver sulfadiazine)
Synedgen, Inc., Louisiana State University Health Sciences Center in New Orleans
Burn Wounds
06/24
06/24
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
Lau, Frank
NCT05120726: A Novel Therapeutic Treatment of Pyoderma Gangrenosum

Recruiting
4
20
US
Dehydrated human amnion/chorion membrane, EpiFix, dHACM
Louisiana State University Health Sciences Center in New Orleans
Pyoderma Gangrenosum
12/24
05/26
MASTR, NCT05243966: Myriad™ Augmented Soft Tissue Reconstruction Registry

Recruiting
N/A
800
US
Myriad Matrix™ and Myriad Morcells™
Aroa Biosurgery Limited
Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury
01/28
01/29
Carter, Jeffrey
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
Hoerger, Michael
EMPOWER 3, NCT04733469: Improving Palliative Care Health Literacy and Utilization

Recruiting
N/A
172
US
Multimedia Psychoeducational Intervention, Enhanced Usual Care
Tulane University, American Cancer Society, Inc., University Medical Center-New Orleans
Cancer, Neoplasm Malignant
04/25
08/25
Ahoubim, Shawn
NCT06393452: Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Active, not recruiting
2
60
US
PP405 0.05% Topical Gel, PP405 Topical Vehicle Gel
Pelage Pharmaceuticals, Inc.
Androgenetic Alopecia
12/24
02/25
NCT05399368: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Terminated
2
229
Canada, US
RPT193, Placebo
RAPT Therapeutics, Inc.
Atopic Dermatitis
05/24
05/24
TONE, NCT05971381: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Completed
N/A
109
US
RECELL® Autologous Cell Harvesting Device, Spray-On SkinTM Cells
Avita Medical
Vitiligo
07/24
01/25
Phelan, Herbert
NCT05023135: DeepView SnapShot Portable (DV-SSP): Device Training Study

Completed
N/A
251
US
DeepView SnapShot Portable (DV-SSP)
SpectralMD
Burns, Wound Heal
04/23
04/23
Hart, Jennifer
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting
4
20000
US
Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet
Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
12/26
12/26
VAYHIA, NCT05648968: A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Recruiting
3
90
Europe, Japan, US, RoW
Ianalumab, VAY736, Placebo
Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
03/26
02/29
Bozant, Emily
GUARDD-US, NCT04191824: Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

Completed
N/A
6754
US
APOL1 status
Duke University, National Human Genome Research Institute (NHGRI), Icahn School of Medicine at Mount Sinai, University of Florida, Indiana University School of Medicine, Vanderbilt University Medical Center
Renal Disease, Hypertension
04/24
05/24
Fusco, Dahlene
NCT04956445: Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development

Recruiting
N/A
2000
US
Tulane University, Centers for Disease Control and Prevention, Gilead Sciences
Covid19
03/25
03/25
Lee, Bridget
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting
4
20000
US
Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet
Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
12/26
12/26
Levi, Yesenia
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting
4
20000
US
Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet
Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
12/26
12/26
Paulsen, Alba Lucia
NCT06131203: Burn Validation Study

Recruiting
N/A
240
US
DeepView SnapShot Portable (DV-SSP)
SpectralMD
Burns, Wound Heal, Wounds and Injuries
03/25
04/25

Download Options